Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

Gallium-68 labeled particles: MAA, lactic acid polymer, and SIR-Spheres

David Trump, Gregory Hiatt, Robert Galloway, Mark Suckow, Mark Green and Seza Gulec
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1460;
David Trump
1Spectron mrc, L.L.C., South Bend, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Hiatt
1Spectron mrc, L.L.C., South Bend, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Galloway
1Spectron mrc, L.L.C., South Bend, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Suckow
2University of Notre Dame, South Bend, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Green
3Purdue University, West Lafayette, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seza Gulec
4Florida International University, Miami, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1460

Objectives Develop PET imaging products to estimate particle distribution in patients being evaluated for Y-90 microsphere selective internal radiation treatment.

Methods 68Ga-MAA was made according to Even and Green* with some modification. To label the decayed SIR-Spheres, sodium acetate (3 N, 0.3 mL) was added to 14 mCi of Ga-68 generator eluate (5ml, 0.1 N HCl) and mixed with approximately 1.9 million decayed SIR-Spheres for 12 minutes. To label the lactic acid polymer, sodium acetate (3 N, 0.23 mL) was added to 15 mCi of Ga-68 generator eluate (0.1 N HCl, 5 mL), followed by 0.25 mL of 1N NaOH. The mixture was added to polylactic acid microspheres (104 mg, 1-50μm), followed by 0.8 mL of 0.1 N sodium hydroxide. Both products were filtered, rinsed with water, and collected in saline or water. Each tracer (100-300 μCi) was administered intravenously to rabbits. PET scans were performed at 10 min, 1 hr and 2 hr.

Results The process time is reasonable for all three tracers, considering the 68 minute half-life of Ga-68. The radiochemical yields were acceptable, except for 68Ga-lactic acid polymer, which was hindered by the propensity of the polymer to stick to surfaces. The PET scans showed little or no activity visible outside the lungs initially and up to 2 hours post-injection, except for the labeled polymer, in which the inclusion of smaller particles allowed visualization of liver and spleen.

Conclusions All tracers exhibit particle-like behavior, appear stable in vivo for up to 2 hours, and may be useful tools for estimation of SIR-Sphere biodistribution. *Even, Gregory A. and Green, Mark A. Int. J. Appl. Instrum. Part B., 16;319-321; 198

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gallium-68 labeled particles: MAA, lactic acid polymer, and SIR-Spheres
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Gallium-68 labeled particles: MAA, lactic acid polymer, and SIR-Spheres
David Trump, Gregory Hiatt, Robert Galloway, Mark Suckow, Mark Green, Seza Gulec
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1460;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Gallium-68 labeled particles: MAA, lactic acid polymer, and SIR-Spheres
David Trump, Gregory Hiatt, Robert Galloway, Mark Suckow, Mark Green, Seza Gulec
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1460;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

  • Adopting radiochemical synthesis of [18F]-FMISO to a multi-step multi-synthesis automated module TS-1
  • Regulatory role of zinc on the altered biokinetics of 65Zn during arsenic induced hepatotoxicity
  • Advancing radiopharmaceuticals through architectural innovation
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

New Radiopharmaceuticals-Broader/General Applications Posters

  • Effect of simvastatin on burn induced changes in tissue specific glucose metabolism
  • An initial investigation of radiolabeling with higher oxidation states of astatine-211. Evaluation of chelation with DOTA and NOTA
  • Target validation of Cu-64 labeled aptamer, AS1411, in lung cancer
Show more New Radiopharmaceuticals-Broader/General Applications Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire